300298.SZ实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 15:04):

Sinocare Inc. engages in the development, manufacture, and marketing of diagnosis rapid testing products primarily in the People's Republic of China...

Stats
今日成交量	4.20M
平均成交量	5.17M
市值	13.29B
EPS	CNY0.256 ( 2023-10-23 )
下一个收益日期	( CNY0 ) 2024-05-21
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	43.44
ATR14	CNY0.0390 (0.16%)

音量相关性

長: -0.08 (neutral)

短: 0.00 (neutral)

Signal:(40.717) Neutral

Sinocare Inc. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Sinocare Inc. 相关性 - 货币/商品

0.25
( neutral )

0.06
( neutral )

0.00
( neutral )

-0.11
( neutral )

0.71
( moderate )

0.13
( neutral )

Sinocare Inc. 财务报表

Annual	2023
营收:	CNY4.06B
毛利润:	CNY2.19B (54.06 %)
EPS:	CNY0.510

FY	2023
营收:	CNY4.06B
毛利润:	CNY2.19B (54.06 %)
EPS:	CNY0.510

FY	2022
营收:	CNY2.81B
毛利润:	CNY1.65B (58.71 %)
EPS:	CNY0.770

FY	2021
营收:	CNY2.36B
毛利润:	CNY1.42B (59.97 %)
EPS:	CNY0.192

Financial Reports:

No articles found.

Sinocare Inc.

Sinocare Inc. engages in the development, manufacture, and marketing of diagnosis rapid testing products primarily in the People's Republic of China. It offers SARS-CoV-2 antibody test strip; Safe-Accu blood glucose monitoring systems; Safe-AQ blood glucose monitoring systems; Gold-Accu blood glucose monitoring systems; Safe-Accu UG blood, glucose, and uric acid monitoring systems; Safe-Accu KG blood, glucose, and ketone monitoring systems; and D Nurse mobile glucose meters. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products to 135 countries. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.